Accelerate timelines and reduce risk in drug development through optimised biomarker analysis
Featuring over 30 presentations, the event brings together leading pharma, biotech and academic organisations working in biomarker analysis and assay development, enabling attendees to discuss emerging applications of analytical tools in translational research
Day One | Multiplex Tools For Biomarker Analysis & Translational Research
Day Two | Cytometry Tools & Therapeutic Applications
Day Three | Novel Assays for Clinical Development & Biomarker Validation
The 2021 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below are some of our confirmed speakers for Advancing Biomarker Analysis Europe: Online
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.
*Free passes are only available to industry R&D or academia.